Literature DB >> 27183206

Neuropathologic Associations of Learning and Memory in Primary Progressive Aphasia.

Stephanie Kielb1, Amanda Cook1, Christina Wieneke2, Alfred Rademaker3, Eileen H Bigio4, Marek-Marsel Mesulam5, Emily Rogalski2, Sandra Weintraub1.   

Abstract

IMPORTANCE: The dementia syndrome of primary progressive aphasia (PPA) can be caused by 1 of several neuropathologic entities, including forms of frontotemporal lobar degeneration (FTLD) or Alzheimer disease (AD). Although episodic memory is initially spared in this syndrome, the subtle learning and memory features of PPA and their neuropathologic associations have not been characterized.
OBJECTIVE: To detect subtle memory differences on the basis of autopsy-confirmed neuropathologic diagnoses in PPA. DESIGN, SETTING, AND PARTICIPANTS: Retrospective analysis was conducted at the Northwestern Cognitive Neurology and Alzheimer's Disease Center in August 2015 using clinical and postmortem autopsy data that had been collected between August 1983 and June 2012. Thirteen patients who had the primary clinical diagnosis of PPA and an autopsy-confirmed diagnosis of either AD (PPA-AD) or a tau variant of FTLD (PPA-FTLD) and 6 patients who had the clinical diagnosis of amnestic dementia and autopsy-confirmed AD (AMN-AD) were included. MAIN OUTCOMES AND MEASURES: Scores on the effortless learning, delayed retrieval, and retention conditions of the Three Words Three Shapes test, a specialized measure of verbal and nonverbal episodic memory.
RESULTS: The PPA-FTLD (n = 6), PPA-AD (n = 7), and AMN-AD (n = 6) groups did not differ by demographic composition (all P > .05). The sample mean (SD) age was 64.1 (10.3) years at symptom onset and 67.9 (9.9) years at Three Words Three Shapes test administration. The PPA-FTLD group had normal (ie, near-ceiling) scores on all verbal and nonverbal test conditions. Both the PPA-AD and AMN-AD groups had deficits in verbal effortless learning (mean [SD] number of errors, 9.9 [4.6] and 14.2 [2.0], respectively) and verbal delayed retrieval (mean [SD] number of errors, 6.1 [5.9] and 12.0 [4.4], respectively). The AMN-AD group had additional deficits in nonverbal effortless learning (mean [SD] number of errors, 10.3 [4.0]) and verbal retention (mean [SD] number of errors, 8.33 [5.2]), which were not observed in the PPA-FTLD or PPA-AD groups (all P < .005). CONCLUSIONS AND RELEVANCE: This study identified neuropathologic associations of learning and memory in autopsy-confirmed cases of PPA. Among patients with clinical PPA syndrome, AD neuropathology appeared to interfere with effortless learning and delayed retrieval of verbal information, whereas FTLD-tau pathology did not. The results provide directions for future research on the interactions between limbic and language networks.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27183206      PMCID: PMC4940228          DOI: 10.1001/jamaneurol.2016.0880

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  27 in total

1.  Three words three shapes: A clinical test of memory.

Authors:  S Weintraub; G M Peavy; M O'Connor; N A Johnson; D Acar; J Sweeney; I Janssen
Journal:  J Clin Exp Neuropsychol       Date:  2000-04       Impact factor: 2.475

2.  The neuropsychological signature of primary progressive aphasia.

Authors:  K K Zakzanis
Journal:  Brain Lang       Date:  1999-10-15       Impact factor: 2.381

3.  Primary progressive aphasia and kindred disorders.

Authors:  Marsel Mesulam; Sandra Weintraub
Journal:  Handb Clin Neurol       Date:  2008

4.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

5.  The Activities of Daily Living Questionnaire: a validation study in patients with dementia.

Authors:  N Johnson; A Barion; A Rademaker; G Rehkemper; S Weintraub
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Oct-Dec       Impact factor: 2.703

6.  Verbal and visuospatial span in logopenic progressive aphasia and Alzheimer's disease.

Authors:  David G Foxe; Muireann Irish; John R Hodges; Olivier Piguet
Journal:  J Int Neuropsychol Soc       Date:  2013-01-08       Impact factor: 2.892

Review 7.  Making the diagnosis of frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  Arch Pathol Lab Med       Date:  2013-03       Impact factor: 5.534

8.  Longitudinal assessment of short-term memory deterioration in a logopenic variant primary progressive aphasia with post-mortem confirmed Alzheimer's Disease pathology.

Authors:  Jeremy Tree; Janice Kay
Journal:  J Neuropsychol       Date:  2014-04-18       Impact factor: 2.864

9.  The mini-mental state examination in behavioral variant frontotemporal dementia and primary progressive aphasia.

Authors:  Jason E Osher; Alissa H Wicklund; Alfred Rademaker; Nancy Johnson; Sandra Weintraub
Journal:  Am J Alzheimers Dis Other Demen       Date:  2007 Dec-2008 Jan       Impact factor: 2.035

10.  Classification and pathology of primary progressive aphasia.

Authors:  Jennifer M Harris; Claire Gall; Jennifer C Thompson; Anna M T Richardson; David Neary; Daniel du Plessis; Piyali Pal; David M A Mann; Julie S Snowden; Matthew Jones
Journal:  Neurology       Date:  2013-10-18       Impact factor: 9.910

View more
  2 in total

1.  Selective verbal recognition memory impairments are associated with atrophy of the language network in non-semantic variants of primary progressive aphasia.

Authors:  Aneesha S Nilakantan; Joel L Voss; Sandra Weintraub; M-Marsel Mesulam; Emily J Rogalski
Journal:  Neuropsychologia       Date:  2017-04-06       Impact factor: 3.139

2.  Memory Resilience in Alzheimer Disease With Primary Progressive Aphasia.

Authors:  M-Marsel Mesulam; Christina Coventry; Alan Kuang; Eileen H Bigio; Qinwen Mao; Margaret E Flanagan; Tamar Gefen; Jaiashre Sridhar; Changiz Geula; Hui Zhang; Sandra Weintraub; Emily J Rogalski
Journal:  Neurology       Date:  2021-01-13       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.